Familial Alzheimer Disease (FAD) Clinical Trial
Official title:
Double-Blind Comparative Trial and Open-Label Extension Trial to Investigate the Safety and Efficacy of TW-012R in Alzheimer's Disease With Presenilin 1 (PSEN1) Mutations
To investigate the safety and efficacy of an orally administered dose of TW-012R in patients with Alzheimer's disease bearing PSEN1 (presenilin 1) mutations (PSEN1-AD), using a placebo group as a control. In addition, long-term safety will be examined in an open-label extension trial.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03657732 -
The Chinese Familial Alzheimer's Network
|
||
Recruiting |
NCT03653156 -
China Cognition and Aging Study
|